Title:
NOVEL ANTI-FGFR2B ANTIBODIES
Document Type and Number:
WIPO Patent Application WO/2021/129655
Kind Code:
A1
Abstract:
The present disclosure provides anti-FGFR2b antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.
Inventors:
WANG MEI (CN)
GUO QIULI (CN)
BAI YU (CN)
YANG ZHENFAN (CN)
ZHANG XIAOLIN (CN)
GUO QIULI (CN)
BAI YU (CN)
YANG ZHENFAN (CN)
ZHANG XIAOLIN (CN)
Application Number:
PCT/CN2020/138580
Publication Date:
July 01, 2021
Filing Date:
December 23, 2020
Export Citation:
Assignee:
DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C12N15/09
Domestic Patent References:
| WO2018129451A2 | 2018-07-12 |
Attorney, Agent or Firm:
JUN HE LAW OFFICES (CN)
Download PDF: